{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "Zimmerman_et_al.__2023_",
  "verification_stats": {
    "total_extracted": 1,
    "verified": 0,
    "rejected": 1,
    "verification_rate": 0.0
  },
  "verified_evidence": [],
  "rejected_evidence": [
    {
      "id": "comp_1",
      "quote": "RIV4 was Flublok",
      "reason": "does not support claim",
      "original_explanation": "This quote directly identifies Flublok as the recombinant influenza vaccine (RIV4) being studied, which is relevant because Flublok is known to be produced using the baculovirus expression vector system (BEVS) in insect cells, supporting the claim about its novel production platform."
    }
  ],
  "model_used": "gpt-4.1"
}